PHAX

Phosphorylated adapter RNA export protein · Q9H814 · PHAX on Sugi Atlas →

0 patent compounds predicted against PHAX, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to PHAX by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL PHASE1/PHASE2RECRUITING
Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma PHASE2RECRUITING
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) PHASE1/PHASE2RECRUITING
Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients PHASE1/PHASE2COMPLETED
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
FAK Inhibitor in Patients With Advanced Solid Tumors PHASE1NOT_YET_RECRUITING
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors PHASE1ACTIVE_NOT_RECRUITING
Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors PHASE1COMPLETED
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Mitigating Mitochondrial RNA Release During Aging to Control Inflammation and Senescence nanNOT_YET_RECRUITING
A Clinical Study on the Efficacy and Safety of Methotrexate (MTX) or Thiotepa (for MTX Intolerance) or Temozolomide (TMZ) Combined With Orelabrutinib and Selinexor in Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma(SELINA) nanRECRUITING
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Ischemic Preconditioning - Perspectives of Use Vivio/in Vitro Studies nanENROLLING_BY_INVITATION
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
miR-155 Expression in Episodic and Chronic Migraine nanUNKNOWN
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress nanWITHDRAWN
Genetic Analysis of Gray Platelet Syndrome nanCOMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML) nanCOMPLETED
Assessment Of Long Noncoding RNA CCAT1 In Colorectal Cancer Patients nanUNKNOWN
Research of Therapeutic Targets in the Frame of Nephronophthisis and Renal Associated Ciliopathies nanRECRUITING
Maximizing Mechanisms of Muscle Hypertrophy to Combat Sarcopenia in Older Adults nanCOMPLETED
Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma nanACTIVE_NOT_RECRUITING
Diagnostic and Prognostic Value of MicroRNA in Breast Cancer Patients nanUNKNOWN
Value of MicroRNA30a in Philadelphia Positive Leukemic Patients nanUNKNOWN
Cytomegalovirus (CMV) MicroRNA Expression in Vivo and Immune Evasion Correlates nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a PHAX binder may also engage these)

ProteinNameSimilarity
Q9JJT9 1.000 Q9JJT9 →
Q5ZLY0 1.000 Q5ZLY0 →
Q3MHI4 1.000 Q3MHI4 →
Q63068 0.990 Q63068 →
Q53F19 0.984 Q53F19 →
Q5ZM19 0.982 Q5ZM19 →
Q5R789 0.981 Q5R789 →
P14629 0.981 P14629 →
Q3ULM0 0.981 Q3ULM0 →
Q61029 0.981 Q61029 →
Q9H2G9 0.981 Q9H2G9 →
A6QR44 0.980 A6QR44 →
Q6PII3 0.980 Q6PII3 →
Q6DE94 0.980 Q6DE94 →
Q96NB3 0.980 Q96NB3 →
Q96G28 0.979 Q96G28 →
E1C760 0.979 E1C760 →
A0JMR6 0.979 A0JMR6 →
Q9ULJ8 0.979 Q9ULJ8 →
Q3MHS2 0.979 Q3MHS2 →
Q8BZR9 0.979 Q8BZR9 →
Q3UQU0 0.979 Q3UQU0 →
Q28E45 0.979 Q28E45 →
Q9CYA6 0.979 Q9CYA6 →
Q7TP65 0.978 Q7TP65 →
P58501 0.978 P58501 →
A5D794 0.978 A5D794 →
Q7L590 0.978 Q7L590 →
Q13625 0.978 Q13625 →
E1BTG2 0.978 E1BTG2 →